Binds HGF receptor system indirectly — angiotensin IV analogue that prevents angiotensinase degradation of HGF, increasing endogenous HGF/c-Met signaling. Potent synaptogenesis promoter: increases dendritic spine density and new synapse formation. Robust cognitive enhancement in animal models.
Studies have administered: Animal: 1mg/kg oral or intranasal; human dosing not established; no clinical trials published
McCoy (2013, Rockefeller): cognitive enhancement in aged and Alzheimer model rats — task performance fully restored. Synaptogenesis: direct imaging confirmed new synapse formation. One of strongest cognitive enhancement signals in published preclinical literature. Human trials absent.
Human safety profile entirely unknown; theoretical concern of uncontrolled synaptogenesis; lipophilic accumulation risk; no clinical trial data
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on Dihexa — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat